Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Division of Cardiology, Severance Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
J Heart Lung Transplant. 2022 Dec;41(12):1751-1760. doi: 10.1016/j.healun.2022.09.008. Epub 2022 Sep 20.
Previous studies regarding donor-recipient size and sex matching in heart transplantation (HTx) mainly included Caucasians with only a small portion of Asians. Even predicted heart mass (PHM) has not yet been elucidated in Asians. We evaluated the association between donor-recipient sex and size matching, including mismatching by PHM, and post-heart transplant survival in Korea.
We enrolled 660 adult HTx recipients between January 2014 and December 2020 using the Korean Organ Transplant Registry data. Recipients were categorized based on donor-recipient PHM, body weight, and sex matching. The primary outcome was 1-year mortality and retransplantation after HTx and survival analyses were performed using Kaplan-Meier method and Cox proportional hazard models.
Among 660 patients, 74 (11.2%), 404 (61.2%), and 182 (27.6%) received undersized (<-15%), matched (-15% to 20%), and oversized (>20%) hearts by PHM, respectively. Size mismatching by PHM was present in a large number of sex-mismatched patients with 85.1% of male donor-female recipients being classified as oversized by PHM and 62.2% of female donor-male recipients being classified as undersized by PHM. Recipients of undersized or oversized hearts by PHM showed an increased 1-year mortality compared with recipients of matched-size hearts (14.8% versus 9.7%; log-rank p = 0.038). The increased mortality persisted after adjusting for other factors affecting mortality (hazard ratio = 1.60, 95% confidence interval: 1.01-2.56). These associations were not shown in obese recipients (body mass index ≥25 kg/m). Heart size mismatching by body weight (log-rank p = 0.332) or sex mismatching (all, log-rank p > 0.05) did not predict 1-year mortality after HTx.
Heart size matching by PHM, not by body weight or sex, was associated with increased 1-year mortality after HTx in Korea.
先前有关心脏移植(HTx)中供受者体型和性别匹配的研究主要包括白种人,只有一小部分是亚洲人。甚至在亚洲人中,也尚未阐明预测的心脏质量(PHM)。我们评估了韩国供受者性别和体型匹配(包括 PHM 不匹配)与心脏移植后生存之间的关系。
我们使用韩国器官移植登记处的数据,纳入了 2014 年 1 月至 2020 年 12 月期间的 660 名成年 HTx 受者。根据供受者 PHM、体重和性别匹配情况对受者进行分类。主要结局是心脏移植后 1 年死亡率和再次移植,采用 Kaplan-Meier 法和 Cox 比例风险模型进行生存分析。
在 660 名患者中,分别有 74 名(11.2%)、404 名(61.2%)和 182 名(27.6%)患者的 PHM 测量值为小于(-15%)、匹配(-15%至 20%)和大于(>20%)。大量的性别不匹配患者存在 PHM 体型不匹配,其中 85.1%的男性供体-女性受者被归类为 PHM 过大,62.2%的女性供体-男性受者被归类为 PHM 过小。与匹配体型心脏的受者相比,PHM 测量值小于或大于的受者 1 年死亡率增加(14.8%比 9.7%;log-rank p=0.038)。调整其他影响死亡率的因素后,这种死亡率的增加仍然存在(风险比=1.60,95%置信区间:1.01-2.56)。在肥胖患者中未显示出这些关联(体重指数≥25 kg/m)。体重(log-rank p=0.332)或性别(所有,log-rank p>0.05)不匹配的心脏大小不匹配与心脏移植后 1 年死亡率无关。
在韩国,PHM 而不是体重或性别匹配的心脏大小与心脏移植后 1 年死亡率的增加有关。